Since CD4+ T cells are critical for protecting against Mtb infection, the enrichment of Th1 cells producing multiple proinflammatory cytokines (e.g., IFN-γ, TNF-α, and IL-2) has been the main focus in the TB vaccine field [64–67]. The gene discussed is IFNG; the disease is tuberculosis.